ClinicalTrials.Veeva

Menu

Transpacific TAVR Registry (TP-TAVR)

D

Duk-Woo Park, MD

Status

Enrolling

Conditions

Heart Valve Diseases
Aortic Valve Insufficiency

Treatments

Procedure: TAVR

Study type

Observational

Funder types

Other

Identifiers

NCT03826264
AMCCV2019-01

Details and patient eligibility

About

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Full description

This study is connected with Asian TAVR registry(NCT02308150). Some subjects from Asian TAVR registry continue 10 years follow-up on this TP-TAVR registry.

Enrollment

10,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • All patients undergoing TAVR
  • Informed consent

Trial design

10,000 participants in 4 patient groups

Korea Centers
Description:
Seoul, Korea All Patients undergoing TAVR
Treatment:
Procedure: TAVR
Stanford University
Description:
California, USA All Patients undergoing TAVR
Treatment:
Procedure: TAVR
Northwestern University
Description:
Evanston, Illinois, USA All Patients undergoing TAVR
Treatment:
Procedure: TAVR
Cheng-Hsin Hospital
Description:
Taipei, Taiwan All Patients undergoing TAVR
Treatment:
Procedure: TAVR

Trial contacts and locations

7

Loading...

Central trial contact

Duk-woo Park, MD; Do-yoon Kang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems